| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tumor Biology |
McGill Centre for Translational Research in Cancer, Lady Davis Institute for Medical Research and Departments of Medicine, Pathology, Oncology, and Pharmacology and Therapeutics, Sir Mortimer B. Davis Jewish General Hospital, Faculty of Medicine, McGill University, Montreal, Quebec, Canada H3T 1E2 [D. W. L., G. B., L. A., H. T. H., G. D. C., M. A. A-J.]; and Department of Anatomy and Cell Biology, University of Western Ontario, London, Ontario, Canada N6A 5C1 [D. W. L., P. F.]
Gap junctions are intercellular channels that are formed from members of a family of proteins, the connexins (Cxs). Gap junctions play an important role in vital functions, including the regulation of cell growth and cell differentiation. Here, we examined the expression of Cx43, a major Cx in breast tissue, in 32 surgical specimens obtained from breast cancer patients who underwent a primary surgical resection prior to chemotherapy or radiotherapy treatments. The expression of Cx43 gap junctions was compared to the levels of estrogen, progesterone, and erbB2 tyrosine kinase receptors. In addition, a panel of breast cancer cell lines and a series of normal rat mammary tissues and rat mammary tumors induced in vivo by dimethylbenz(a)anthracene were studied. We demonstrated that the lack of Cx43 gap junctions is a common feature of human mammary cancer tissues compared to nonneoplastic breast tissues surrounding primary tumors. Cx43 gap junctions were not observed in ductal carcinomas in situ, infiltrating ductal carcinomas, and infiltrating lobular carcinomas, and they seem to be independent of estrogen, progesterone, and erbB2 receptor status. In breast cancer cell lines and rodent mammary carcinoma tissues, down-regulation of Cx43 occurs at the mRNA level, suggesting a transcriptional mechanism for the decrease of Cx43 protein in breast cancer. In summary, this study provides evidence of decreased expression of Cx43 gap junctions in breast cancer at various stages of progression as well as breast cancer cell lines and raises the possibility that Cx43 may be a useful marker for detecting early oncogenesis in the breast. Because Cx43 gap junctions are lacking in breast cancer and restoration of Cx43 has been shown to reverse the malignant phenotype in vitro, pharmacological up-regulation of Cx43 may prove beneficial in cancer therapeutics.
This article has been cited by other articles:
|
|
 |
|
  D. Tattersall, C. A. Scott, C. Gray, D. Zicha, and D. P. Kelsell EKV mutant connexin 31 associated cell death is mediated by ER stress Hum. Mol. Genet., December 15, 2009; 18(24): 4734 - 4745. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bier, I. Oviedo-Landaverde, J. Zhao, Y. Mamane, M. Kandouz, and G. Batist Connexin43 pseudogene in breast cancer cells offers a novel therapeutic target Mol. Cancer Ther., April 1, 2009; 8(4): 786 - 793. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Chalabi, L. Delort, S. Satih, P. Dechelotte, Y.-J. Bignon, and D. J. Bernard-Gallon Immunohistochemical Expression of RAR{alpha}, RAR{beta}, and Cx43 in Breast Tumor Cell Lines After Treatment With Lycopene and Correlation With RT-QPCR J. Histochem. Cytochem., September 1, 2007; 55(9): 877 - 883. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Shen, P. R. Khusial, X. Li, H. Ichikawa, A. P. Moreno, and G. S. Goldberg Src Utilizes Cas to Block Gap Junctional Communication Mediated by Connexin43 J. Biol. Chem., June 29, 2007; 282(26): 18914 - 18921. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. P.K. Lai, J. F. Bechberger, R. J. Thompson, B. A. MacVicar, R. Bruzzone, and C. C. Naus Tumor-Suppressive Effects of Pannexin 1 in C6 Glioma Cells Cancer Res., February 15, 2007; 67(4): 1545 - 1554. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M.J. Conklin, J. F. Bechberger, D. MacFabe, N. Guthrie, E. M. Kurowska, and C. C. Naus Genistein and quercetin increase connexin43 and suppress growth of breast cancer cells Carcinogenesis, January 1, 2007; 28(1): 93 - 100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kalra, Q. Shao, H. Qin, T. Thomas, M. A. Alaoui-Jamali, and D. W. Laird Cx26 inhibits breast MDA-MB-435 cell tumorigenic properties by a gap junctional intercellular communication-independent mechanism Carcinogenesis, December 1, 2006; 27(12): 2528 - 2537. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. McLachlan, Q. Shao, H.-l. Wang, S. Langlois, and D. W. Laird Connexins Act as Tumor Suppressors in Three-dimensional Mammary Cell Organoids by Regulating Differentiation and Angiogenesis. Cancer Res., October 15, 2006; 66(20): 9886 - 9894. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. D. Han, K. Suzuki, H. Koike, K. Suzuki, H. Yoneyama, S. Narumi, F. Shimizu, and H. Kawachi IFN-Inducible Protein-10 Plays a Pivotal Role in Maintaining Slit-Diaphragm Function by Regulating Podocyte Cell-Cycle Balance J. Am. Soc. Nephrol., February 1, 2006; 17(2): 442 - 453. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Shao, H. Wang, E. McLachlan, G. I.L. Veitch, and D. W. Laird Down-regulation of Cx43 by Retroviral Delivery of Small Interfering RNA Promotes an Aggressive Breast Cancer Cell Phenotype Cancer Res., April 1, 2005; 65(7): 2705 - 2711. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Pfeifer, C. Anderson, R. Werner, and E. Oltra Redefining the structure of the mouse connexin43 gene: selective promoter usage and alternative splicing mechanisms yield transcripts with different translational efficiencies Nucleic Acids Res., August 24, 2004; 32(15): 4550 - 4562. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. King and P. D. Lampe Mice deficient for the gap junction protein Connexin32 exhibit increased radiation-induced tumorigenesis associated with elevated mitogen-activated protein kinase (p44/Erk1, p42/Erk2) activation Carcinogenesis, May 1, 2004; 25(5): 669 - 680. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Thomas, D. Telford, and D. W. Laird Functional Domain Mapping and Selective Trans-dominant Effects Exhibited by Cx26 Disease-causing Mutations J. Biol. Chem., April 30, 2004; 279(18): 19157 - 19168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Jensen and P. M. Glazer Cell-interdependent cisplatin killing by Ku/DNA-dependent protein kinase signaling transduced through gap junctions PNAS, April 20, 2004; 101(16): 6134 - 6139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-T. Chen, Y.-W. Cheng, M.-C. Chou, T. Sen-Lin, W.-W. Lai, W. L. Ho, and H. Lee The Correlation between Aberrant Connexin 43 mRNA Expression Induced by Promoter Methylation and Nodal Micrometastasis in Non-Small Cell Lung Cancer Clin. Cancer Res., September 15, 2003; 9(11): 4200 - 4204. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Qin, Q. Shao, S. A. Igdoura, M. A. Alaoui-Jamali, and D. W. Laird Lysosomal and Proteasomal Degradation Play Distinct Roles in the Life Cycle of Cx43 in Gap Junctional Intercellular Communication-deficient and -competent Breast Tumor Cells J. Biol. Chem., August 8, 2003; 278(32): 30005 - 30014. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Solan, M. D. Fry, E. M. TenBroek, and P. D. Lampe Connexin43 phosphorylation at S368 is acute during S and G2/M and in response to protein kinase C activation J. Cell Sci., June 1, 2003; 116(11): 2203 - 2211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Husoy, V. Cruciani, H. K. Knutsen, S.-O. Mikalsen, H. B. Olstorn, and J. Alexander Cells heterozygous for the ApcMin mutation have decreased gap junctional intercellular communication and connexin43 level, and reduced microtubule polymerization Carcinogenesis, April 1, 2003; 24(4): 643 - 650. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. D. Carystinos, M. Kandouz, M. A. Alaoui-Jamali, and G. Batist Unexpected Induction of the Human Connexin 43 Promoter by the Ras Signaling Pathway Is Mediated by a Novel Putative Promoter Sequence Mol. Pharmacol., April 1, 2003; 63(4): 821 - 831. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Qin, Q. Shao, H. Curtis, J. Galipeau, D. J. Belliveau, T. Wang, M. A. Alaoui-Jamali, and D. W. Laird Retroviral Delivery of Connexin Genes to Human Breast Tumor Cells Inhibits in Vivo Tumor Growth by a Mechanism That Is Independent of Significant Gap Junctional Intercellular Communication J. Biol. Chem., August 2, 2002; 277(32): 29132 - 29138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Plante, M. Charbonneau, and D. G. Cyr Decreased gap junctional intercellular communication in hexachlorobenzene-induced gender-specific hepatic tumor formation in the rat Carcinogenesis, July 1, 2002; 23(7): 1243 - 1249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Fritz, L. Kunz, N. Dimitrijevic, R. Grunert, C. Heiss, and A. Mayerhofer Muscarinic Receptors in Human Luteinized Granulosa Cells: Activation Blocks Gap Junctions and Induces the Transcription Factor Early Growth Response Factor-1 J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1362 - 1367. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. G. A. Harks, A. D. G. de Roos, P. H. J. Peters, L. H. de Haan, A. Brouwer, D. L. Ypey, E. J. J. van Zoelen, and A. P. R. Theuvenet Fenamates: A Novel Class of Reversible Gap Junction Blockers J. Pharmacol. Exp. Ther., September 1, 2001; 298(3): 1033 - 1041. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. D. Lampe, E. M. TenBroek, J. M. Burt, W. E. Kurata, R. G. Johnson, and A. F. Lau Phosphorylation of Connexin43 on Serine368 by Protein Kinase C Regulates Gap Junctional Communication J. Cell Biol., June 26, 2000; 149(7): 1503 - 1512. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
